NCT06072976 The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies
| NCT ID | NCT06072976 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seattle Children's Hospital |
| Condition | Gastrointestinal Complication |
| Study Type | INTERVENTIONAL |
| Enrollment | 116 participants |
| Start Date | 2023-06-09 |
| Primary Completion | 2027-06-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 116 participants in total. It began in 2023-06-09 with a primary completion date of 2027-06-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study explores the use of an exclusive human milk diet versus standard feeding practices to compare the influence on feeding outcomes and the gut bacteria in infants with intestinal differences.
Eligibility Criteria
Inclusion Criteria: * Infants with gastroschisis, giant omphalocele, intestinal atresia, mid-gut volvulus, hirschsprungs disease. Exclusion Criteria: 1. Infant has already been on feeds 2. Infants \<34 weeks gestation 3. Parents with contraindications to providing milk (i.e. drug use-cocaine, fentanyl, meth BUT oxy/suboxone/marijuana OK) 4. Complicated gastroschisis 5. Short gut syndrome 6. Additional congenital anomalies that affect ability to tolerate milk (i.e. cyanotic congenital heart disease BUT kidney disease ok)
Contact & Investigator
Katie Strobel, MD
PRINCIPAL INVESTIGATOR
Seattle Children's Hospital
Frequently Asked Questions
Who can join the NCT06072976 clinical trial?
This trial is open to participants of all sexes, aged 0 Days or older, up to 55 Years, studying Gastrointestinal Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06072976 currently recruiting?
Yes, NCT06072976 is actively recruiting participants. Contact the research team at leonel.arellano@seattlechildrens.org for enrollment information.
Where is the NCT06072976 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT06072976 clinical trial?
NCT06072976 is sponsored by Seattle Children's Hospital. The principal investigator is Katie Strobel, MD at Seattle Children's Hospital. The trial plans to enroll 116 participants.